Follow The Filings

APPN Appian Corporation

Information Technology, filed as APPIAN CORP (CL A), Equity Among managers we track Quote on Google Finance, opens in a new tab

No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.

Insider trades

Open-market buys and sales by APPN's executives, directors and 10% owners in the last 12 months, from their Form 4s

All APPN insider trades
  • $100K bought by 1 insider
  • $257K sold by 1 insider outside a trading plan
  • $7.3M sold by 1 insider under 10b5-1 plans
  1. Matthew W Calkins CEO
    Planned sale
    $1.7M 45,000 shares at $37.50 2.8% of stake
    Traded Oct 7 Filed Oct 8
    ↗
  2. Matthew W Calkins CEO
    Planned sale
    $1.6M 45,000 shares at $35.19 2.7% of stake
    Traded Sep 8 Filed Sep 10
    ↗
  3. Matthew W Calkins CEO
    Planned sale
    $1.6M 45,000 shares at $34.46 2.6% of stake
    Traded Aug 7 Filed Aug 11
    ↗
  4. Matthew W Calkins CEO
    Planned sale
    $1.2M 50,000 shares at $24.72 2.8% of stake
    Traded Jul 7 Filed Jul 8
    ↗
  5. Matthew W Calkins CEO
    Planned sale
    $1.2M 50,000 shares at $24.13 2.7% of stake
    Traded Jun 8 Filed Jun 10
    ↗
  6. Mark Dorsey Chief Revenue Officer
    Buy
    $100K 5,227 shares at $19.13 +60% to stake
    Traded May 13 Filed May 13
    ↗
  7. Mark Steven Lynch Director
    Sale
    $257K 9,530 shares at $27.00 18% of stake
    Traded Mar 3 Filed Mar 3
    ↗

Also filed in the last 12 months, not counted as buying or selling: 23 stock grants, 11 share withholdings for taxes, 11 option exercises, and 6 conversions.

Congress

No member of Congress reported trading APPN in the last three years. 1 member listed it in 2025 annual reports.

All Congress trades

SEC filings

Recent issuer filings from EDGAR, 11 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
8-K 5.07,9.01 Filing Doc
8-K 2.02,8.01,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 2 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $545.36M $617.02M $726.94M
Gross profit $402.04M $466.84M $527.34M
Gross margin * 73.7% 75.7% 72.5%
Net income -$111.44M -$92.26M $1.23M
Net margin * -20.4% -15.0% 0.2%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $414.36M $435.54M $519.42M
Total non-current assets * $213.15M $185.5M $171.97M
Total assets $627.5M $621.04M $691.4M
Total current liabilities $371.17M $354.76M $452.11M
Total non-current liabilities * $203.99M $298.92M $286.28M
Total equity $52.34M -$32.64M -$46.99M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$110.44M $6.88M $62.87M
Cash from investing $28.59M -$35.39M -$12.83M
Cash from financing $79.16M -$0.258M -$36.28M
Net change in cash -$1.03M -$30.8M $17.26M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf